Literature DB >> 22447367

Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients.

Shawna Kraft, Emily Mackler, Peter Schlickman, Kathy Welch, Daryl D DePestel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22447367     DOI： 10.1007/s00520-012-1440-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  1 in total

1.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079
  1 in total
  2 in total

Review 1.  Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.

Authors:  Bhavarth S Shukla; Timothy P Gauthier; Ricardo Correa; Laura Smith; Lilian Abbo
Journal:  Int J Clin Pharm       Date:  2013-07-27

2.  Vancomycin-resistant Enterococcus faecium Bacteremia in a tertiary care hospital: epidemiology, antimicrobial susceptibility, and outcome.

Authors:  Regis G Rosa; Alexandre V Schwarzbold; Rodrigo P Dos Santos; Eduardo E Turra; Denise P Machado; Luciano Z Goldani
Journal:  Biomed Res Int       Date:  2014-03-05       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.